ATE381350T1 - Geschmacklose, direkt verpressbare, schnelllösliche komplexe und ihre pharmazeutischen zusammensetzungen. - Google Patents

Geschmacklose, direkt verpressbare, schnelllösliche komplexe und ihre pharmazeutischen zusammensetzungen.

Info

Publication number
ATE381350T1
ATE381350T1 AT04005469T AT04005469T ATE381350T1 AT E381350 T1 ATE381350 T1 AT E381350T1 AT 04005469 T AT04005469 T AT 04005469T AT 04005469 T AT04005469 T AT 04005469T AT E381350 T1 ATE381350 T1 AT E381350T1
Authority
AT
Austria
Prior art keywords
tasteless
complex
basic drug
pharmaceutical compositions
quickly dissolving
Prior art date
Application number
AT04005469T
Other languages
English (en)
Inventor
Hardeep Wadhwa
Original Assignee
Ind Swift Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/383,433 external-priority patent/US20030170310A1/en
Application filed by Ind Swift Ltd filed Critical Ind Swift Ltd
Application granted granted Critical
Publication of ATE381350T1 publication Critical patent/ATE381350T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04005469T 2003-03-07 2004-03-08 Geschmacklose, direkt verpressbare, schnelllösliche komplexe und ihre pharmazeutischen zusammensetzungen. ATE381350T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/383,433 US20030170310A1 (en) 2002-03-08 2003-03-07 Tasteless, directly compressible, fast-dissolving complexes and pharmaceutical formulations thereof

Publications (1)

Publication Number Publication Date
ATE381350T1 true ATE381350T1 (de) 2008-01-15

Family

ID=32824799

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04005469T ATE381350T1 (de) 2003-03-07 2004-03-08 Geschmacklose, direkt verpressbare, schnelllösliche komplexe und ihre pharmazeutischen zusammensetzungen.

Country Status (4)

Country Link
EP (1) EP1454635B1 (de)
AT (1) ATE381350T1 (de)
DE (1) DE602004010732T2 (de)
ES (1) ES2298637T3 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2999937B1 (fr) * 2012-12-21 2015-01-09 Sanofi Sa Unite solide a haute teneur en fexofenadine et son procede de preparation
CN115721613B (zh) * 2021-08-27 2024-02-09 长春澜江医药科技有限公司 一种含有盐酸非索非那定的药物组合物及其制剂

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine

Also Published As

Publication number Publication date
EP1454635B1 (de) 2007-12-19
DE602004010732T2 (de) 2008-12-24
ES2298637T3 (es) 2008-05-16
DE602004010732D1 (de) 2008-01-31
EP1454635A1 (de) 2004-09-08

Similar Documents

Publication Publication Date Title
WO2003075829A3 (en) Tasteless directly compressible fast-dissolving complexes and pharmaceutical formulations thereof
MXPA03006476A (es) Composiciones farmaceuticas, formas de dosificacion y metodos para administracion oral de epotilonas.
GEP201706611B (en) Amido compounds and their use as pharmaceuticals
DZ3227A1 (fr) Compositions pharmaceutiques fournissant des concentrations de medicaments ameliorees
SE0104341D0 (sv) New use
MXPA04005877A (es) Composiciones farmaceuticas de derivados de taxano oralmente activos con biodisponibilidad mejorada.
WO2005065185A3 (en) Temperature-stable formulations, and methods of development thereof
WO2006024486A3 (en) Amide derivatives of 3-phenyl dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents
NO20080827L (no) Faste doseringsformuleringer av narkotiske legemidler som har forbedret bukal adsorpsjon
IL213806A0 (en) Use of derivatives of n-phenylpiperazin-1-yl-acetamide for the preparation of a pharmaceutical compositions for treatment of diabetes related conditions
ATE543489T1 (de) Orale dosierformen mit progesteron und verwendungs- und herstellungsverfahren dafür
ATE519486T1 (de) Pharmazeutische zusammensetzung mit einem monoamin-neurotransmitter-wiederaufnahmehemmer und einem acetylcholinesterase-hemmer
NO20014738L (no) Tolperisonholdig farmasöytisk preparat for oral administrering
IL159217A0 (en) An oral pharmaceutical formulation comprising a basic pharmaceutically active ingredient having ph-dependent solubility, a process for the manufacture thereof and use thereof in medicine
DE50210906D1 (de) Arzneimittel enthaltend deuterium zur behandlung der zuckerkrankheit
DE60102590T2 (de) Darreichungsformen zur behandlung von oralen mykosen
WO2004098594A3 (en) Dosage form containing pantoprazole as active ingredient
WO2003020214A3 (en) Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
DK1696922T3 (da) Anvendelse af et hydroximinsyre-halogenid-derivat til behandling af neurodegenerative sygdomme
MXPA06010146A (es) Formas de dosificacion solidas biodisponibles de metaxalona.
ATE381350T1 (de) Geschmacklose, direkt verpressbare, schnelllösliche komplexe und ihre pharmazeutischen zusammensetzungen.
WO2004098577A3 (en) Dosage form containing (s)-pantoprazole as active ingredient
TR200301553A1 (tr) İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar
EP1581196A4 (de) Säurelabile arzneimittelzusammensetzungen
WO2006039268A3 (en) Pharmaceutical formulations containing vitamin e tpgs molecules that solubilize lipophilic drugs without significant efflux inhibition, and use of such formulations

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties